Patients with heart failure who remained on mineralocorticoid receptor antagonists after a hyperkalemia episode had a lower risk for major cardiovascular events than those who stopped taking the medications, a study found.
A study of 1029 living kidney donors in Norway found that they had significant 64% increased odds of ischemic heart disease compared with health controls.
Among patients with chronic kidney diseases, the presence of sarcopenia, compared with its absence, is significantly associated with an approximately 2-5 times increased risk of death, a study found.
In a study, cardiovascular structure and function at 5 years did not differ significantly among living kidney donors and healthy controls.
Higher vitamin D doses than recommended in guidelines are needed to prevent fractures in kidney transplant recipients with low vitamin D levels, according to investigator.
Patients with chronic kidney disease and metabolic acidosis treated with sodium bicarbonate experienced decreased risks of a doubling of serum creatinine, initiation of renal replacement therapy, and death.
Long-term survival of kidney transplant recipients is similar regardless of donor gender, British investigators report.
In a study of chronic kidney disease patients not on dialysis, hyperkalemia developed in more women than men.
Proton pump inhibitor use by patients with CKD stage 3 to 5 is associated with 54% and 35% increased risks of acute kidney injury and death, respectively, a study found.
In a small study, 34% of dialysis patients had vertebral fractures, and patients in the highest tertile of parathyroid hormone level had a nearly 3-fold increased risk of these fractures compared with those in the middle tertile.
Please login or register first to view this content.
